学術論文 |
- "PGV-1 permanently arrests HepG2 cells in M phase and inhibits liver carcinogenesis in DMH-induced rats," Journal of Applied Pharmaceutical Science, vol.13, no.8, pp204-211, 4 Aug. 2023
- Dhania Novitasari, Jun-ya Kato, Dyaningtyas Dewi Pamungkas Putri, Febri Wulandari, Sitarina Widyarini, Ummi Maryam Zulfin, Dhiya Ulhaq Salsabila, Edy Meiyanto
- "Chemoprevention curcumin analog 1.1 promotes metaphase arrest and enhances intracellular reactive oxygen species levels on TNBC MDA-MB-231 and HER2-positive HCC1954 cells," Research in Pharmaceutical Sciences, vol.18, no.4, pp358-370, 1 Jul. 2023
- Dhania Novitasari, Riris Istighfari Jenie, Jun-ya Kato, Edy Meiyanto
- "Curcumin analogs PGV-1 and CCA-1.1 induce cell cycle arrest in human hepatocellular carcinoma cells with overexpressed MYCN," The Indonesian Biomedical Journal, vol.15, no.2, pp141-149, 18 Apr. 2023
- Moordiani Moordiani, Dhania Novitasari, Ratna Asmah Susidarti, Jun-ya Kato, Edy Meiyanto
- "Network Pharmacological Analysis Identifies the Curcumin Analog CCA-1.1 Targeting Mitosis Regulatory Process in HER2-Positive Breast Cancer.," ndonesian Journal of Pharmacy, vol.34, no.1, 1 Jan. 2023
- Dhania Novitasari, Riris Istighfari Jenie, Jun-ya Kato, Edy Meiyanto
- "Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models," Scientific Reports, vol.12, no.1, pp22419, 27 Dec. 2022
- Naoki Kamitani, Ikuko Nakamae, Noriko Yoneda-Kato, Jun-ya Kato, Masayuki Sho
 [ doi:10.1038/s41598-022-26863-y ]
- "Preparation and cytotoxic evaluation of PGV-1 derivative, CCA-1.1, as a new curcumin analog with improved-physicochemical and pharmacological properties," Advanced pharmaceutical bulletin, vol.12, no.3, pp603, May. 2022
- Rohmad Yudi Utomo, Febri Wulandari, Dhania Novitasari, Beni Lestari, Ratna Asmah Susidarti, Riris Istighfari Jenie, Jun-ya Kato, Sardjiman Sardjiman, Edy Meiyanto
- "CCA-1.1 exerts cytotoxic activities against TNBC and HER2-enriched breast cancer: in vitro and bioinformatic studies," CANCER SCIENCE, vol.113, pp1030, 1 Feb. 2022
- Novitasari Dhania, Febri Wulandari, Rohmad Y Utomo, Riris I Jenie, Jun-ya Kato, Edy Meiyanto
- "Targeting Abnormal Cell Cycle in Cancer: A Preface to the Special Issue," Onco, vol.2, no.1, pp34-35, 13 Jan. 2022
- Chiaki Takahashi, Jun-ya Kato
- "The integrative bioinformatic analysis deciphers the predicted molecular target gene and pathway from curcumin derivative CCA-1.1 against triple-negative breast cancer (TNBC)," Journal of the Egyptian National Cancer Institute, vol.33, no.1, pp1-10, Dec. 2021
- Dhania Novitasari, Riris Istighfari Jenie, Jun-ya Kato, Edy Meiyanto
- "A new curcumin analog, CCA-1.1, induces cell death and cell cycle arrest in WiDr colon cancer cells via ROS generation," Journal of Applied Pharmaceutical Science, vol.11, no.10, pp99-105, 3 Oct. 2021
- Febri Wulandari, Muthi Ikawati, Mitsunori Kirihata, Jun-ya Kato, Edy Meiyanto
- "The Two Mono-Carbonyl Curcumin Analogs, PGV-1 and CCA-1.1: The Chemopreventive Activity Against DMH-Induced Colorectal Cancer Rat and Proteins Target Candidate Involved," Research Square, 1 Oct. 2021
- Febri Wulandari, Mitsunori Kirihata, Sitarina Widyarini, Jun-ya Kato, Edy Meiyanto
[ doi:10.21203/rs.3.rs-950137/v1 ]
- "Curcumin Analogs, PGV-1 and CCA-1.1 Exhibit Anti-migratory Effects and Suppress MMP9 Expression on WiDr Cells," The Indonesian Biomedical Journal, vol.13, no.3, pp271-280, 9 Sep. 2021
- Febri Wulandari, Mitsunori Kirihata, Jun-ya Kato, Edy Meiyanto
- "Synthetic Inhibitors of CDK4/6 Activities and Tumor Suppression: A Preface to the Special Issue," Onco, vol.1, no.1, pp1-2, Sep. 2021
- Chiaki Takahashi, Jun-ya Kato
- "Curcumin-like structure (CCA-1.1) induces permanent mitotic arrest (Senescence) on Triple-negative breast cancer (TNBC) cells, 4T1," Research Journal of Pharmacy and Technology, vol.14, no.8, pp4375-4382, Aug. 2021
- Dhania Novitasari, Riris Istighfari Jenie, Febri Wulandari, Rohmad Yudi Utomo, Dyaningtyas Dewi Pamungkas Putri, Jun-ya Kato, Edy Meiyanto
- "Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development," The Journal of clinical investigation, vol.131, no.12, 15 Jun. 2021
- Hidenori Ito, Ikuko Nakamae, Jun-ya Kato, Noriko Yoneda-Kato
- "CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti-Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells," Asian Pacific Journal of Cancer Prevention: APJCP, vol.22, no.6, pp1827, Jun. 2021
- Dhania Novitasari, Riris Istighfari Jenie, Rohmad Yudi Utomo, Jun-ya Kato, Edy Meiyanto
- "Evaluation of Cytotoxic Activity of Curcumin Like Structure (CCA-1.1) Against Metastatic Breast Cancer Cells," CANCER SCIENCE, vol.112, pp934, 1 Feb. 2021
- Dhania Novitasari, Riris I Jenie, Dyaningtyas DD Putri, Febri Wulandari, Jun-ya Kato, Edy Meiyanto
- "The Target Differences of Anti-Tumorigenesis Potential of Curcumin and Its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells.," Advanced Pharmaceutical Bulletin, 30 Sep. 2020
- Meiyanto E,, Husnaa U,, Kastian RF,, Putri H,, Larasati YA,, Khumaira A,, Pamungkas DDP,, Jenie RI,, Kawaichi M,, Lestari B,, Yokoyama T,, Jun-ya Kato
[ doi:10.34172/apb.2021.020 ]
- "New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells," Indonesian Journal of Pharmacy, pp244-256, Apr. 2020
- F Wulandari, D Novitasari,, M Kirihata, Jun-ya Kato, E Meiyanto
- "Curcumin derivatives verify the essentiality of ROS upregulation in tumor suppression," Molecules, vol.24(22), pp4067-4067, 10 Nov. 2019
- Ikuko Nakamae, Tsumoru Morimoto, Hiroki Shima, Masafumi Shionyu, Hisayo Fujiki, Noriko Yoneda-Kato, Takashi Yokoyama, Shigehiko Kanaya, Kiyomi Kakiuchi, Tsuyoshi Shirai, Edy Meiyanto, Jun-ya Kato
[ doi:10.3390/molecules24224067 ]
- "Pentagamavunon-1 (PGV-1) inhibits ROS metabolic ensymes and suppresses tumor cell growth by including M phase (prometaphase) arrest and cell senescence," Scientific Report, vol.9, pp14867-14867, 16 Oct. 2019
- Beni Lestari, Ikuko Nakamae, Noriko Yoneda-Kato, Tsumoru Morimoto, Shigehiko Kanaya, Takashi Yokoyama, Masafumi Shionyu, Tsuyoshi Shirai, Edy Meiyant, Jun-ya Kato
[ doi:10.1038/s41598-019-51244-3 ]
- "Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence. ," Scientific Reports, 4 Oct. 2019
- Beni Lestari,, Ikuko Nakamae, Noriko Yoneda-Kato,, Tsumoru Morimoto, Shigehiko Kanaya, Takashi Yokoyama, Masafumi Shionyu, Tsuyoshi Shirai,, Edy Meiyanto, Jun-ya Kato
 [ NAISTレポジトリ ] [ doi:10.1038/s41598-019-51244-3 ]
- "Anti-Proliferative and Anti-Metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (Pgv-1), Toward Highly Metastatic Breast Cancer Cells in Correlation With Ros Generation. ," Advanced Pharmaceutical Bulletin, vol.9, no.3, pp445-452, 1 Sep. 2019
- Meiyanto E, Putri H, Arum Larasati Y,, Yudi Utomo R, Jenie RI,, Ikawati M, Lestari B, Yoneda-Kato N, Nakamae I, Kawaichi M, Jun-ya Kato
- "Cell cycle modulation of CHO-K1 cells under Genistein treatment correlates with cells senescence, apoptosis and ROS level but in a dose-dependent manner. ," Advanced Pharmaceutical Bulletin, vol.9, no.3, pp453-461, 1 Sep. 2019
- Jenie RI,, Amalina ND, Ilmawati GPN, Utomo RY, Ikawati M, Jun-ya Kato, Meiyanto E
- "Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth,," Scientific Reports, vol.8, pp2039, 1 Feb. 2018
- Yonika Arum Larasati, Noriko Yoneda-Kato, Ikuko Nakamae, Takashi Yokoyama, Edy Meiyanto, Jun-ya Kato
[ NAISTレポジトリ ]
- "Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia.," Blood Adv. , vol.1, no.20, pp1682-1693, 12 Sep. 2017
- Nakamae I, Jun-ya Kato, Takashi Yokoyama, Ito H, Yoneda-Kato N
[ doi:10.1182/bloodadvances.2017007054. eCollection 2017 Sep 12. ]
- "COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1. ," Blood, vol.122, pp1750-1760, Sep. 2013
- Yoshida A, Jun-ya Kato, Nakamae I, Noriko Kato
- "The COP1 E3-ligase interacts with FIP200, a key regulator of mammalian autophagy.," BMC Biochem. , vol.14, no.1, 6 Jun. 2013
- Kobayashi S, Noriko Kato, Itahara N, Yoshida A, Jun-ya Kato
[ doi:10.1186/1471-2091-14-1 ]
- "CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner.," Sci Rep. 2013;. . Epub 2013 Jan 11. PMID: 23316279, no.3:1054, 11 Jan. 2013
- Yoshida A, Noriko Kato, Jun-ya Kato
[ doi:10.1038/srep01054 ]
- "Effects on Transcription of Mutations in ygjD, yeaZ, and yjeE Genes, Which Are Involved in a Universal tRNA Modification in Escherichia coli," J Bacteriol, vol.193, no.21, pp6075, Nov. 2011
- Hashimoto, C, Sakaguchi, K, Taniguchi, Y, Honda, H, Oshima, T, Ogasawara, N, Kato, J.
- "Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.," Anticancer Res., vol.29, pp2015, 2009
- Shiraso S, Katayose Y, Yamamoto K, Mizuma M, Yabuuchi S, Oda A, Rikiyama T, Onogawa T, Yoshida H, Hayashi H, Ohtsuka H, Motoi F, Egawa S, Kato J, Unno M.
|
